Investor directoryBoehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund is dedicated to advancing scientific innovation in therapeutics.
In numbers
In the last 24 months, Boehringer Ingelheim Venture Fund took part in 3 funding rounds on record at Oka. The most recent round on record is from July 2025.
As of October 2026. Source: Oka, counted from funding rounds reported in the press; rounds that were never reported are not included.
The facts
- Typical cheque
- €1M – €30M
- Headquarters
- Ingelheim am Rhein, Germany
- Founded
- 2010
Portfolio companies
More portfolio companies
and 21 more
Recent rounds
Aignostics
$34M (approximately €31M)Series BAI / MLAthos CapitalleadBoehringer Ingelheim Venture FundHTGFCARMA FUNDVC Fonds Technologie managed by IBB VenturesWellington
Germanysiliconcanals.com
Rounds Boehringer Ingelheim Venture Fund took part in, as reported by the linked articles. See who else is investing right now.
Questions founders ask
- How much does Boehringer Ingelheim Venture Fund typically invest?
- Boehringer Ingelheim Venture Fund states a typical cheque of €1M – €30M.
- Which stages does Boehringer Ingelheim Venture Fund invest in?
- Boehringer Ingelheim Venture Fund invests at Seed, Series A and Series B.
- Where is Boehringer Ingelheim Venture Fund based?
- Boehringer Ingelheim Venture Fund is headquartered in Ingelheim am Rhein, Germany.
Does Boehringer Ingelheim Venture Fund fit your round?
In 30 minutes you'll know which funds matter for your round.
Get a demoSearch investors like this in Claude — no account, no sign-in. Open in Claude
Are you Boehringer Ingelheim Venture Fund? Tell us what to correct and we will update it — or ask us to remove the entry.